Ultrasound contrast developer Acusphere has been informed by Nasdaq that it does not comply with the minimum stockholders' equity requirement of $10 million for continued listing on the Nasdaq Global Market.
As a result, the company's common stock is subject to delisting unless Acusphere addresses this deficiency at the company's hearing before the Nasdaq Listing Qualifications Panel in the first half of September. The Watertown, MA-based firm said it would request continued listing on either the Nasdaq Global Market or the Nasdaq Capital Market based on its plan for demonstrating compliance with the applicable listing requirements.
Related Reading
Acusphere reports Q2 results, August 12, 2008
Acusphere cuts staff, July 29, 2008
Acusphere gets Nasdaq warning letter, July 15, 2008
FDA to review Acusphere's Imagify, July 1, 2008
Acusphere revenues flat for Q1 2008, May 9, 2008
Copyright © 2008 AuntMinnie.com
